Inovio Pharmaceuticals earnings were -$107.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest INO earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$19.4M, down 23% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INO reported annual earnings of -$107.3M, with -20.6% growth. The next INO earnings date is May 12, 2025.
Inovio Pharmaceuticals Earnings Reports & History FAQ
What were Inovio Pharmaceuticals's earnings last quarter?
On INO's earnings call on Invalid Date, Inovio Pharmaceuticals (NASDAQ: INO) reported Q4 2024 earnings per share (EPS) of -$0.60, up 44.44% year over year. Total INO earnings for the quarter were -$19.38 million. In the same quarter last year, Inovio Pharmaceuticals's earnings per share (EPS) was -$1.08.
The next INO earnings call is Invalid Date. Add INO to your watchlist to be reminded of Inovio Pharmaceuticals's next earnings date.
What was INO's earnings growth in the past year?
As of Inovio Pharmaceuticals's earnings date in Invalid Date, Inovio Pharmaceuticals's earnings has grown year over year. INO earnings in the past year totalled -$107.25 million.
Is Inovio Pharmaceuticals profitable or losing money?
As of the last Inovio Pharmaceuticals earnings report, Inovio Pharmaceuticals is currently losing money. Inovio Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$107.25 million, a 20.62% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.